Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Submitted by
admin
on June 9, 2015 - 12:00pm
Source:
Fierce Biotech
News Tags:
Celegene
Lycera
M&A
cancer
T-cells
Headline:
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Do Not Allow Advertisers to Use My Personal information
